mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.11 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |